Recurrent lymphocytic myocarditis in a young male with ulcerative colitis

European Journal of Medical Research

Antonios Katsounas²  Rolf A Janosi⁴  Raimund Erbel⁴  Guido Gerken²  Hideo A Baba¹  Thomas Schlosser³  Felix Nensa³  Mareike Perrey⁴  Nico Reinsch⁴  Varnavas C Varnavas⁴ 

[1] Institute of Pathology and Neuropathology, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany;Department of Gastroenterology and Hepatology, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany;Institute of Diagnostic and Interventional Radiology, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany;Department of Cardiology, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany

关键词: heart failure;    lymphocytic myocarditis;    Ulcerative colitis;   

Others  :  817563
DOI  :  10.1186/2047-783X-19-11

 received in 2013-10-17, accepted in 2014-02-17,  发布年份 2014

【 摘 要 】

Awareness of myocarditis in association with inflammatory bowel diseases is crucial as it bears a rare but serious risk for mortality. This report describes the case of a young Caucasian male, whose heart biopsy was tested negative for giant cells and bacterial or viral genomes or proteins. He was experiencing severe lymphocytic myocarditis (other than mesalamine-induced) along with cardiogenic shock during ulcerative colitis exacerbation. This is an extremely rare, if not unique, clinical constellation. We chose to study the epidemiologic grounds and all major aspects of differential pathogenesis and treatment of this serious health problem.

【 授权许可】

   
2014 Varnavas et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Mowat NA, Bennett PN, Finlayson JK, Brunt PW, Lancaster WM: Myopericarditis complicating ulcerative colitis. Br Heart J 1974, 36:724-727.
• [2]Sorensen HT, Fonager KM: Myocarditis and inflammatory bowel disease. A 16-year Danish nationwide cohort study. Dan Med Bull 1997, 44:442-444.
• [3]Freeman HJ, Salh B: Recurrent myopericarditis with extensive ulcerative colitis. Can J Cardiol 2010, 26:549-550.
• [4]Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW: Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation 1991, 83:953-961.
• [5]Cooper LT Jr, Berry GJ, Shabetai R: Idiopathic giant-cell myocarditis – natural history and treatment. N Engl J Med 1860–1866, 1997:336.
• [6]Davies MJ, Pomerance A, Teare RD: Idiopathic giant cell myocarditis – a distinctive clinico-pathological entity. Br Heart J 1975, 37:192-195.
• [7]Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A: Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107:857-863.
• [8]Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333:269-275.
• [9]Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001, 104:39-45.
• [10]Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH: Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 2004, 25:587-610.
• [11]Stelts S, Taylor MH, Nappi J, Van Bakel AB: Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother 2008, 42:904-905.
• [12]Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239-245.